Michelle A. Hurchla

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Norihiko Watanabe, Maya Gavrieli, John R. Šedý et al. · Nature Immunology · 2003 · 872 citations

Life Sciences, Immunology, Oncology +12

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

John R. Šedý, Maya Gavrieli, Karen G. Potter et al. · Nature Immunology · 2004 · 621 citations

Life Sciences, Immunology, Molecular Biology +13

B and T Lymphocyte Attenuator Exhibits Structural and Expression Polymorphisms and Is Highly Induced in Anergic CD4+ T Cells

Michelle A. Hurchla, John R. Šedý, Maya Gavrielli et al. · The Journal of Immunology · 2005 · 178 citations · Full text

Life Sciences, Genetics, Immunology +16

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects

Michelle A. Hurchla, Antonio García-Gómez, Mary C. Hornick et al. · Leukemia · 2012 · 143 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling

Xinming Su, Desiree H. Floyd, Alun D. Hughes et al. · Journal of Clinical Investigation · 2012 · 102 citations · Full text

Medicine, Cell Biology, Pharmacology +17